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Abstract: Purpose: 
To assess a novel method of 3D co-registration of prostate MRI exams 
performed before and after prostate cancer focal therapy. 
 
Material and method:  
We developed a software platform for automatic 3D deformable co-
registration of prostate MRI at different time points and applied this 
method to ten patients who underwent focal ablative therapy.  MRI exams 
were performed preoperatively, as well as one week and six months post-
treatment. Rigid registration served as reference for assessing co-
registration accuracy and precision. 
 
Results:  
Segmentation of preoperative and postoperative prostate revealed a 
significant post-operative volume decrease of the gland that averaged 
6.49 cc (p=0.017). Applying deformable transformation based upon Mutual 
Information (MI) from 120 pairs of MRI slices, we refined by 2.9 mm (max 
6.25mm) the alignment of the ablation zone (AZ), segmented from contrast-
enhanced images on the one-week post-operative exam, to the 6-month post-
operative T2-weighted images. This represented a 500% improvement over 
the rigid approach (p=0.001), corrected by volume. The dissimilarity by 
Dice index of the mapped AZ using deformable transformation vs. rigid 
control was significantly (p=0.04) higher at the ablation site compared 
to the whole gland. 
 
Conclusion:  
Our findings illustrate our method's ability to correct for deformation 
at the ablation site.  The preliminary analysis suggests that deformable 
transformation computed from MI of pre-operative and follow-up MRI is 
accurate in co-registration of MRI exams performed before and after focal 
therapy. The ability to localize the previously ablated tissue in 3D 
space may improve targeting for image-guided follow-up biopsy within 







































































3D registration of mpMRI 
for assessment of prostate cancer focal therapy 
 
Short Title 




Contemporary methods of multi-parametric MRI (mpMRI) of the prostate have greatly 
improved the ability of radiologists and urologists to detect prostate cancer 1. mpMRI 
allows physicians to diagnose clinically significant cancer in its early stage, to plan 
prostatectomy and radiation therapy, and to detect local recurrence.  
Combined with the trend of earlier detection, noninvasive prostate cancer therapies 
are gaining interest. Focal therapies (FT) aim to combine oncologic benefit with 
preserved continence and erectile function. The use of this tissue preservation 
approach is evolving and FT is being applied to more aggressive disease than when 
initially proposed 2,3. Clinical FT trials depend on mpMRI for tumor localization, 
treatment planning, and post-treatment follow-up 4–7.  
 
There is no consensus regarding optimal assessment of oncologic success of FT 3,8,9. 
Current criteria of successful FT involve negative histology at the treatment site. 
Different methods have been proposed to detect cancer recurrence after FT. While 
invasive transrectal prostate biopsy or transperineal mapping biopsy are often 
performed, mpMRI-targeted biopsy has shown promising results 10,11. Such 
assessment by MRI requires an ability to delineate on imaging the ablation zone (AZ) 
that is characterized histologically by homogeneous coagulation necrosis 12,13. In 
addition, it has been suggested 14,15, that mpMRI underestimates the total tumor 



































































volume, requiring to include some surrounding margin within the AZ for a complete 
focal ablation. After treatment, dynamic contrast-enhanced (DCE) MRI delineates AZ 
as a devascularized,  non-enhancing area 4. Within several weeks after treatment, 
the AZ shrinks, often leading to a changed configuration of the gland 9,16.  
These novel therapeutic developments require a reliable and accurate software 
system for assessment of the changes in the prostate gland, including tissue 
necrosis, due to ablation. To be effective, such a system must depict how the viable 
tissue is reorganized around the AZ. Thereby requiring a comparison of pre-
treatment and post treatment images of the prostate. Development of image 
registration methods for this application is challenging. First, one must register 
longitudinal MRI, including different sequences, across different time points. Second, 
inherent in focal therapy, the tissue changes are inhomogeneous. Third, the 
variations in shape between the preoperative and postoperative exams are highly 
dependent on treatment delivery, location of the tumor, energy choice, as well as 
surrounding tissues. These factors makes it difficult to use a normative atlas to 
facilitate registration.   
 
Fei et al. 17 described a mutual Information based rigid-transform method to align a 
preoperative prostate T2 weighted (T2W) imaging sequence to an intra operative 
sequence. Wu et al. 18 combined mutual Information measure with low-order 
polynomial transformation to register spectroscopy with the prostate deformed by 
inflated intra-rectal balloon. Using a finite elements method (FEM), Marami et al 19 
validated a registration approach between MRI acquired with an endorectal coil and 
the intraoperative MRI. Toth et al. 20 also used FEM to model the changes in prostate 




































































It has been have previously demonstrated that the deformation of the gland after 
surgery is well captured by the affine transformation T that incorporates nonisotropic 
3D sheer and stretch factors 21. This technique was also found to accurately define a 
3D target for focal therapy based on MRI findings 14. We have now implemented an 
image-based framework for accurate estimation of the affine transform from the pre-
FT to the post-FT MRI. This study evaluates the method using longitudinal mpMRI 
acquired before and after modern interstitial laser22 and photodynamic FT23. This 
study aims to assess this novel method of 3D co-registration of prostate MRI exams 
performed before and after prostate cancer focal therapy, in order to facilitate focal 
therapy follow up. 
 
Material and Methods 
Patients  
Ten male patients, aged 65 +/- 6.4 years, diagnosed with localized prostate cancer at 
biopsy (median PSA 5.1ng/ml, median Gleason Score 6) underwent FT. Five patients 
were treated by interstitial laser procedure within the MRI bore 4 and five by 
photodynamic therapy, included in an earlier publication23. Local institutional review 
board approved this study. 
Image acquisition 
All patients underwent a pre-operative mpMRI, and two follow-up post-operative 
mpMRI (one week and 6 months after treatment, fig.1) using 3T Magnetom Trio 
system equipped with a pelvic phase array (Siemens Healthcare, Erlangen, 
Germany). Each exam used identical MpMRI protocol that included a T2W sequence, 





































































The anatomical T2W images through the pelvis were acquired using turbo spin-echo 
sequence with parameters: TR = 4950 ms, TE = 122 ms, axial orientation, 256 x 256 
acquisition matrix, no interslice gap, 180 x 180 mm field of view, 3 mm slice 
thickness, 3 signal averages.  
Diffusion weighted sequence was based on axial fat-suppressed single shot 
echoplanar imaging with TR=4100 ms, TE=86 ms, diffusion gradient b-values of 50 
and 1000 s/mm2; slice thickness 3 mm; 100 x 100 matrix; 200 x 200 mm field of 
view,10 signal averages. ADC maps were reconstructed inline.  
DCE-MRI exam consisted of continuous acquisition of T1-weighted 3 mm thick 
contiguous images (240 x 240 mm field of view; matrix 128 x 128) every 15 sec after 
IV administration of 0.1 mmol/kg of gadopentetate dimeglumine (Magnevist; Bayer 
HealthCare Pharmaceuticals, Montville, NJ). The contrast agent was administered as 
an intravenous bolus via power injector (Spectris; Medrad, Warrendale, Pa), followed 
by a 20-mL saline flush, both administered at a 3 mL/sec injection rate. 
Image analysis 
Our image processing workflow (figure 2) includes estimating 3D rigid body 
coregistration of mpMRI modalities within each exam; and image coregistration 
across-exams using non-rigid (affine) transform. 
 
Coregistration framework  
The user interaction consists of a reduction of the field of view to the prostate gland 



































































A senior urological surgeon performed this step. 
 There are several novel features of the system: 1) the parameters of the affine 
transform T are estimated only from prostate tissue, thus ignoring confounding signal 
from adjacent regions like the muscle, rectum or the bladder; 2) the iterative voxel-
similarity algorithm is supplemented by the multi-dimensional gridding of initial 
parameters. The goal is to make the estimate of T insensitive of the initial value and 
to avoid being trapped in a suboptimal local optimum; and 3) the software is 
designed to be used on multi-core platforms. 
Image coregistration consists of two tasks: determining the transformation T that 
relates points in the source image V1 with the corresponding points in the target 
image V2 and applying the transformation T to the source image, resulting in the 
coregistered volume V2’ = T(V1). Signal interpolation is another necessary step. Our 
coregistration process is controlled using the dialog box shown in figure 3. The 
optimization is done in two stages:  
1) “Autofocus” stage: exhaustive search over multiple initial approximations drawn 
from a discrete grid of parameters that define T (6 parameters for rigid body, 12 
parameters for affine transform). The most promising candidates (those having 
largest similarity measure) are passed to the second, fine-tune stage. The number of 
selected candidates is controlled by the "power" factor P. Large values of P may 
improve the accuracy of coregistration at the cost of longer processing time. 
2) “Fine-tune” stage: iterative search for a local maximum of the similarity measure 
(initialized at P settings from autofocus stage). We refine P most promising affine 
transforms using the parallelized implementation of the Nelder–Mead algorithm, a 



































































intensity differences25, signal correlation 26, uniformity of ratio image27,28, and mutual 
information (MI) and normalized MI 29–32. Mutual Information33 (MI) was selected as 
the similarity metric due to its demonstrated robustness in multimodality registration, 
especially when applied within-subject. MI has been used successfully in registration 
of prostate MRI17,18. While signal characteristics of untreated and treated tissue may 
be different, untreated portions of the gland constitute a vast majority of tissue 
volume3. 
Our framework allows the user to restrict the similarity measure to a predefined 3D 
region called "target". In this study the target region was the prostate and 
immediately (approximately 5 mm margin) surrounding tissue 34. The idea is to focus 
the similarity on the organ of interest, while ignoring possible misalignment of 
background structures as well as confounding image (curves of bladder neck or 
anterior wall of rectum). 
 
Estimating transformations within-exam and across exams  
The parameters for coregistering different MRI sequences within each exam were: 
target ROI=yes, subsample=3, autofocus grid = 10mm, rotation = 10°, transform = 
rigid, measure = mutual information, interpolation = sinc.  Coregistration of MRI 
sequences across exams used the similar parameters except transform = affine, 
scale deformation=2 and shear=5. Here a rigid method was explored as a control for 
affine, to assess the significance of deformation (stretching and sheering) induced by 




































































For each patient and each exam, the resulting transformations were saved for later 
recall, to be applied to landmarks or subregion masks (ROI) placed within the source 
volume. This allowed visualization of AZ from the 1 week post-FT MRI superimposed 
over the prostate 6-month post-FT.  
The coregistration software was written in C++ using Microsoft Foundation Class and 
Intel Threading Building Blocks libraries. The program exploits parallel processing.  
 
Error analysis and segmentation of prostate gland and ablation zone 
 
To analyze registration error, two operators   with experience in prostate anatomy   
manually segmented in consensus the different 3D masks (or ROIs): preoperative 
prostate, 6 months post operative prostate, and AZ. ROIs excluded the seminal 
vesicles. The first two ROIs were traced on T2W images.  Segmentation of the AZ, 
which was visualized in all 10 cases, was derived from the latest DCE time-point from 
the 1-week post-FT MRI (Fig. 4B). Ground truth segmentation was done in 
consensus by a radiologist  who completed an abdominal radiology fellowship with 
over 5 years’ experience in interpretation of prostate mp MRI and a senior urological 
surgeon with 3 years in practice. The geometrical transformations T estimated in the 
process of coregistration were applied to these 3D ROIs. 
 
The ROIs served to assess the accuracy of rigid and non-rigid transformation models 
(Fig. 5). It should be noted here that a future clinical/surgical use of the system does 




































































We have measured the mismatch between transformed pre-op region and the region 
manually segmented at follow-up, the latter considered as the ground truth. Three 
types of error measures were evaluated:  
1) volume changes -- while important, this measure is the least informative, as unlike 
the other two measures it doesn't capture subtle shape changes.  
2) the Hausdorff distance (HD), defined here as the maximum distance (in 
millimeters) between the structure boundaries 14. The HD was obtained for each slice 
composing an ROI. For each multislice ROI, the average of the maximum HD for 
each slice was calculated resulting in an average maximum HD. The purpose is to 
have 3D information for each ROI. 
3) Dice index 21 was defined as the volume ratio Di=             . The Dice 
index measures the normalized similarity between two different 3D masks ROIs 
based on their overlap. 
 
The co-registration process aims to transfer the location of the effectively ablated 
zone AZ based on early post contrast MRI to its residual location within the late 
control MRI. We further analyzed how the rigid Tr(V1) and non-rigid Ta(V1) 
transforms computed from mutual information measure for the entire gland (M=mask 
of whole gland) is able to align the AZ on V2 (late post-FT), as illustrated in figure 2. 
This entails direct comparison of the derived target for post-FT follow-up between the 
compensated AZ2’=Ta(Tdce(AZ)) and non-compensated deformations 
AZ2’’=Tr(Tdce(AZ)). We compared Di AZ2’/ AZ2’’ to Di  M2’=Ta(M)/ M2’’=Tr(M) (figure 6, 
C). This compares the performances of the two algorithms at the location of the AZ to 
those for whole gland mapping. Analogously, we compared the HD for the same 





































































These measures were compared using the paired t-test or Wilcoxon signed rank test 
(for data that didn't satisfy Shapiro-Wilk test of normality).  A p value less than 0.05 
was used to establish significance. All tests were done using R statistical software, 





There was a significant ~14% reduction in prostate volume (table 1, figure 6) 
between an average of 46.5 ml pre-FT to 40.0 ml post-FT (p=0.017, paired T-test, 
mean 6.50, 95% confidence interval (CI) [1.46 - 11.54]). The volume of the AZ obtained 
by direct segmentation was significantly correlated (R=0.738, p= 0.015) with the 
difference in prostate volume between the pre-FT and post-FT examinations. 
However, the volume of AZ was on the average 13.8 ml, approximately double the 
difference D in pre-FT and post-FT volumes (table 1) and statistically different from D 
(paired t-test, T=-2.38, p=0.04; mean diff 7.33,   95% CI [0.38 - 14.27]). 
The blue bars in figure 6 illustrates the significant difference in volume between the 
rigid and deformable transforms of the whole prostate over the late post operative 
prostate at 6 months MRI, i.e.. M2’ vs M2’’. 
Analysis of image coregistration 
The 10 cases represented MRI volumes composed in total of 120 pair of slices for 



































































converged successfully and we were able to assess both non-rigid and rigid 
transformation for coregistration of the pre-FT and post-FT images. The software 
architecture successfully exploited multi-core processor parallelism  and shown by 
high loading on a 12-core CPU system (figure 7). A representative example is shown 
in figure 4.  
 
Table 2 compares of volume between the rigid M2’’, which serves as a control, and 
deformable M2’ transforms of the whole gland. The transforms of the pre-FT prostate 
to the post-FT prostate yielded a significantly lower volume (p=0.041; mean 
difference 2.3, 95% IC[0.1132 ; 4.4868])) using non-rigid transformation 
compared to the rigid approach (table 2). The difference of less than 1% of prostate 
volume after rigid transformation might be imputable to the interpolation errors, as 
rigid transformation conserve volume through. 
 
Table 3 lists the average values of Dice index and HD for the alignment of the whole 
gland described in Figure 6, AB. While the alignment is better (smaller HD, larger 
overlap) for affine transform, the difference didn’t reach significance (p=0.10 and 
0.20). These comparisons suggest a trend for higher accuracy using the non-rigid 
transformation.  
 
Analysis of AZ 
 
When whole gland was taken in account, the non-rigid transformation Ta provided 



































































HD (or 0.72mm/ml, p=0.0019) and Di= 0.87 (p=0.046) versus HD=3.83 mm ( or 
0.15mm mm/ml), and Di=0.93. 
Figure 8 illustrates the changes between pre and post treatment MRI at the ablated 





The role of image registration in prostate cancer pathway 
Image coregistration plays an increasingly important role in prostate cancer. It 
permits us to characterize MR signal and image texture of cancer tissue through 
histological validation 21,35,36. There is a great interest in developing ultrasound biopsy 
fused to MRI 37–40. Image registration will also play an important role in both planning 
and follow-up of FT. This entails accurate mapping of lesion mask derived from pre-
treatment mpMRI to the space of treatment and post treatment images 14.  
 
The ability of contrast enhanced imaging, either ultrasound or MRI to visualize 
necrotic tissue permits initial assessment of FT 41. Several studies 3,8,9 converge by 
defining oncologic success of FT as negative biopsy at the treated area. (PSA is not 
helpful for monitoring FT outcome 42). Histologic post FT assessment depends on 
either random transrectal or transperineal approach 16,43. Transrectal option is prone 
to substantial sampling error and a high rate of false negative results. Transperineal 
mapping option requires repeat general anesthesia 44. mpMRI offers the promise to 
guide post-FT biopsy and overcome these limitations  42,43,45,46. However there are 




































































A critical step is to accurately locate AZ at follow-up biopsy to (a) evaluate the energy 
deposition within AZ, and/or (b) sample the surrounding tissue (tumor margin). The 
objective is to detect and manage treatment failure or cancer recurrence and possibly 
offer re-treatment. This task requires detecting low-volume cancer 42 and it requires 
exquisite precision. Ven et al. 48 estimated that, given a 0.3 ml target, a precision of 
1.9 mm is necessary to correctly grade 95% of aggressive tumor component in 
peripheral zone. The report of the START consortium concludes that defining the 
target for biopsy and being able to reliably sample such area remain fundamental 
problems [3]. The challenge is intensified if a lesion is poorly demarcated on the post-
FT images or it there are significant spatial deformations between pre- and post-FT 
images. To address this need, our study estimated the margin of error in AZ using 
affine transform and a novel coregistration framework. We chose rigid registration as 
a control.  
 
 
Challenge for image registration 
The current standard in radiologic in oncology are RECIST criteria, that unfortunately 
are subjective and don’t involve image registration. There is very limited literature on 
longitudinal registration describing the deformation of the gland after local treatment 
16,46. A recent report 20 aims to quantify changes of the gland after focal laser ablation 
using the finite elements method (FEM) align pre- and post-operative T2W images. 
The study notes the importance of knowing biomechanical properties of the tissue, 




































































Post-treatment volume loss  
We have observed a mean decrease in gland volume of 6.50 cc or 12.9%. This is 
significantly lower than the volume of the AZ, although the two measures were 
significantly correlated. Toth et al. 20 reported a similar decrease in gland volume at 
the same follow-up time delay in response to laser ablation. Volume shrinkage is 
likely due to the process of cicatrization with fibrosis 49. If confirmed, accounting for 
volume change will be an important requirement of any longitudinal analysis software. 
Clearly, volume-preserving rigid body coregistration is not capable to reflect volume 




Our image coregistration technique helps to assess FT and demonstrates that local 
treatment influences the deformation of the entire gland. We have observed the 
similarity of boundary changes at the gland (global) and the AZ (local) level. Both 
Dice Index and HD show the effect of non-rigid algorithm at AZ. The change in mean 
HD of 2.9 mm (maximum ~6 mm) between rigid and a non-rigid mapped AZ indicates 
the advantage of the deformable model to define an area of interest. This observation 
is important because it implies that currently available systems that ignore shrinkage 
may leave unsampled residual tissue and fail to detect residual/recurrent disease.  
 
We have also demonstrated that changes in AZ are well modeled by the affine 
transform. Normalized HD resulting from affine compensation was 0.75 mm/cc for the 
AZ, which is almost five times better than 0.15 mm/cc for the whole gland. The lower 



































































(0.93) indicates the higher dissimilarity of the rigid and non-rigid transforms at this 
very zone of interest. These data indicate that the residual tissue at the former AZ 
location is more accurately mapped in the post-FT MRI using the non-rigid approach 
than without such compensation. This important finding shows the ability to 
successfully model tissue changes at the location of cancer that can be visualized on 
baseline mpMRI. Intensity changes at the location of the ablation were also reported 
by Toth et al. 20.  
 
We attribute good performance of longitudinal coregistration (all the attempted 
registrations were successful) to the use of discrete parameter gridding, introduced to 
avoid being trapped in local maxima. Moreover, our method computes the similarity 
measures from prostate alone. The reduced field of view decreases the 
computational effort and is not influenced by tissue motion outside the prostate. 
Mutual Information has been used in several applications for prostate registration like 
histology-MRI correlation21,50, intra procedural registration of MRI for focal 
ablation.17,51. The computation of the joint histogram for MI, as a fully image based 
method, seems to enable the registration. Longitudinal registration of medical 
imaging is still an area of active research53. The implementation of multi-core 
parallelism enables one to complete this complex task on standard desktop computer 
in a few minutes.  
 
Limitations 
We have evaluated the registration technique using volumetric and linear metrics 



































































identifiable landmarks are hard to detect on post-operative images. Assessment of 
the method in a larger cohort would be useful for validation of those initial findings.  
Our coregistration procedure includes manual steps in which the operator delineates 
the prostate gland and surrounding (approximately 5 mm) tissue. In a future study we 
plan to investigate (a) the relationship between the size of the mask and registration 
accuracy, and (b) inter-observer variability of the method. 
Clinical implications 
This work suggests that longitudinal image transformation may guide the location of 
targeted biopsy after FT. The shrinkage of AZ can be modeled prior to follow-up 
biopsy and incorporated in a US-guided sampling system 54.  A recent study 
evocated the benefit of a TRUS-MRI fusion platform that corrects for deformation on 
ultrasound due to the probe insertion, as compared to "cognitive registration" 55. Such 
implementation could also be used for in MR bore biopsy procedure56. Using 
longitudinal coregistration, one could consistently re-visit the same gland location 57, 
without limitations of implantable/imageable pellets proposed recently by Ghai et 
Tranchtenberg 58. Recently, Natarajan et al. 59 rose the question of assessment of 
treatment margin in their report of a phase 1 trial about focal therapy using in bore 
laser ablation with a transrectal approach. Our method may assist to discriminate 
infield/ outfield recurrence after focal therapy. Figure 9 summarizes the potential 
clinical implementation of our findings in focal therapy pathway and follow up.  
 
Toth and associates 20 provide preliminary validation of a competing framework 
based on FEM and requiring modeling the elastic effects of the bladder and the 
rectum. A direct comparison between FEM and purely image-based framework would 



































































focal therapy procedures, our preliminary experience suggests the clinical utility of 
affine algorithms for mapping mpMRI findings between pre- and post-FT scans. Our 
workflow could be also extended to transformation models that involve higher degree 
of freedom. The longitudinal coregistration technique could also be applied to other 
image-guided procedures like liver ablation60 or focal kidney-sparing cancer therapy 
61. 
 
In summary, we have proposed a novel coregistration framework that has potential to 
provide image-guided target for post-FT biopsy. The affine algorithm can 
compensate and correct the deformation of an ablated zone and reach the needed 
accuracy of several millimeters. The technique offers the possibility to re-visit cancer 
location which was targeted and to plan follow up biopsy, facilitating accurate and 




































































































Figure 1: Timeline of treatment and imaging exams. 
 
Figure 2: Image analysis workflow. 
 
Figure 3: The dialogue box defines the registration process 
 
Figure 4: Illustrative case of affine registration between pre-treatment (A) and 
post-treatment (photodynamic therapy) T2W volumes (C). Panel (B) shows 
delayed DCE image of the treated area, with ablated gland shown as non 
enhancing region. The bottom panel displays a postoperative T2W image 
overlayed with the corresponding preoperative image.  
 
Figure 5: Schematic illustration of various measures assesses in current study. 
A: analysis of errors in whole gland definition for rigid transform model M2 vs 
M2’’;  B: analysis of errors for affine transform model M2 vs M2’; C: analysis of 
errors in defining AZ (AZ2’-AZ2’’) vs (M2’- M2’’). 
 
Figure 6: Comparison between median pre-operative and 6 months post-
operative volumes of the prostate (orange bars). Comparison between median 
volume generated with rigid and non-rigid transforms (blue bars) shows that 
non-rigid trans-formation compensates better for volume loss due to focal 
therapy.  
 
Figure 7:  Demonstration of high CPU core usage on a 12-core computer achieved 
during registration. 
 
Figure 8: Post-surgical changes for a representative case involving dynamic 
phototherapy on left lobe. A,B: 3D rendering before and post treatment. 
Changes in shape and volume loss are observed in the left part of the gland. 
The pre-treatment view shows in red the lesion 10 mm in axial diameter, 



































































ablated zone. This yellow area needs to be sampled to rule out cancer at 
follow-up biopsy. The green line segment is the needle path for transperineal 
targeted biopsy. C: preoperative T2W image. D: preoperative ADC map. E: 
preoperative DCE image through the cancer focus (white arrow). F: late 
postoperative T2W image. G, post operative ADC map H: DCE image at the 
same level. Changes in shape and MRI signal are discernible at the site of 
ablation on the left side of the gland.  
 
Figure 9: graphical summary of implementation of 3D registration of mpMRI into focal 
therapy of prostate cancer pathway. Overlays of the prostate segmentation are 
presented on the extreme right MRI image with the green line as the post ablation 
segmentation, the blue the preoperative registered prostate using the non-rigid 
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Table 1: Distribution of prostate volumes estimated from T2W images 
acquired before and after ablation (late control) and distribution of volume of 
ablated zone (AZ).  
 
  Prostate volume from T2W images Ablated Volume (cc) 





 volume (cc) 
Difference 
D (cc) 
median 51.64 46.73 6.70 7.88 
mean 46.49 39.99 6.50 13.82 
SD 23.67 20.25 7.05 13.67 
min 8.42 6.80 -3.60 1.07 






Table 2. Comparison of volumes between original T2 WI and their 











median 50.71 48.22 
mean 45.41 43.23 
SD 22.81 21.17 
min 7.99 7.17 
max 81.02 73.67 
Table2
Table 3: Alignment between whole gland obtained by mapping from 
pre-operative to post-operative T2W image and whole gland traced 




Rigid registration Tr Affine registration Ta 
 
Hausdorff distance (mm)  
median 7.73 7.29 
mean 8.14 6.91 
max 9.46 9.98 
min 5.31 4.64 
SD 1.45 1.60 
p value p=0.20 
 
Dice index 
mean 0.82 0.84 
median 0.85 0.85 
max 0.91 0.92 
min 0.68 0.72 
SD 0.08 0.06 
p value p=0.10 
Table3
Table 4. Compensation of the local deformation by affine algorithm: 
comparison between mapping accuracy of the location of the ablated 





Ta(AZ) vs Tr (AZ) Ta(M) vs Tr (M) 
 
Hausdorff distance (mm) 
median 1.99 3.83 
mean 2.99 3.84 
max 6.25 7.05 
min 1.10 1.10 
SD 2.10 2.21 
 
Normalized Hausdorff distance (mm/ml) 
mean 0.72 0.15 
median 0.22 0.09 
max 1.09 0.55 
min 0.05 0.03 
sd 0.57 0.17 
p value p=0.0019 
 
Dice index 
mean 0.87 0.93 
median 0.87 0.92 
max 0.96 0.98 
min 0.59 0.88 
SD 0.11 0.04 
p value p=0.046  
Table4
